Given the aggressive nature and lack of targeted therapies for TNBC, we subsequently aimed at identifying unique lncRNA transcripts expressed in TNBC, but not ER+ BC, which could potentially be used as prognostic biomarkers and therapeutic targets. Here, ESR1 is linked to breast cancer.